Cyclophosphamide: Phase II trials




By Russell Logan in Shout About ME.


Norwegian researchers have commenced phase II trials of the anti-cancer drug cyclophosphamide on ME/CFS patients.

Led by senior consultant Dr Øystein Fluge and Prof Olav Mella, the team is focusing on non-responders and those patients who have relapsed after treatment with rituximab, a B-cell depleting drug.

Forty patients with moderate to serious myalgic encephalomyelitis (ME) (sometimes referred to as me/cfs or chronic fatigue syndrome) are taking part in the cyclophosphamide trial, which began in March this year and is scheduled for completion by September 2016.


To read the rest of this story, click on the link below:

Link to ME Research story

Leave a Reply

The York ME Community © 2015
Powered by Live Score & Live Score App